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Abstract
Study design—Cross-sectional survey with longitudinal follow-up
Objectives—To test the hypothesis that pain which is localised to the low back differs 
epidemiologically from that which occurs simultaneously or close in time to pain at other 
anatomical sites
Summary of background data—Low back pain (LBP) often occurs in combination with other 
regional pain, with which it shares similar psychological and psychosocial risk factors. However, 
few previous epidemiological studies of LBP have distinguished pain that is confined to the low 
back from that which occurs as part of a wider distribution of pain.
Methods—We analysed data from a cohort study of musculoskeletal pain and associated 
disability in 47 occupational groups from 18 countries.
Results—Among 12,197 subjects at baseline, 609 (4.9%) reported localised LBP in the past 
month, and 3,820 (31.3%) non-localised LBP. Non-localised LBP was more frequently associated 
with sciatica in the past month (48.1% vs. 30.0% of cases), occurred on more days in the past 
month and past year, was more often disabling for everyday activities (64.1% vs. 47.3% of cases), 
and had more frequently led to medical consultation and sickness absence from work. It was also 
more often persistent when participants were followed up after a mean of 14 months (65.6% vs. 
54.1% of cases). In adjusted Poisson regression analyses, non-localised LBP was differentially 
associated with female sex, older age, somatising tendency, poor mental health and report of time 
pressure at work,. There were also marked differences in the relative prevalence of localised and 
non-localised LBP by occupational group.
Conclusions—Future epidemiological studies should distinguish where possible between pain 
that is limited to the low back and LBP which occurs in association with pain at other anatomical 
locations.
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Introduction
Low back pain (LBP) is a major cause of disability among people of working age [1], but 
investigation of its causes has been hindered by challenges in case definition. In most people 
with LBP, there is no clearly demonstrable underlying spinal pathology, and even where the 
pain occurs in association with structural abnormalities such as disc herniation or nerve root 
compression, only a minority of cases are attributable to the observed pathology [2]. In the 
absence of more objective diagnostic criteria, most epidemiological studies have defined 
cases according to report of symptoms and/or accompanying disability, and this approach 
has given useful insights. For example, we know that LBP is associated with heavy lifting 
and other physical activities which subject the spine to mechanical stresses [3], although 
disappointingly, ergonomic interventions in the workplace to reduce such exposures have 
failed to prevent back problems [4]. Associations have also been found with psychological 
characteristics such as low mood [5–7], tendency to worry about common somatic 
symptoms (somatising tendency) [5,7], adverse health beliefs about musculoskeletal pain 
[6], and (to a lesser extent) psychosocial aspects of work [8].
The same psychological and psychosocial risk factors have been linked also with other 
regional musculoskeletal pain, for example in the upper limb [8,9] and knee [10]; and 
somatising tendency has shown particularly strong associations with multi-site pain [11]. 
Moreover, LBP frequently occurs in combination with pain at other anatomical sites, either 
simultaneously or close in time [12–15]. This raises the possibility that the observed 
associations of LBP with psychological and psychosocial risk factors might reflect effects on 
musculoskeletal pain more generally, and that pain which is limited only to the low back is 
epidemiologically distinct from that which occurs as part of a wider distribution of pain. If 
this were the case, studies that failed to distinguish localised from non-localised LBP might 
miss associations with preventable causes, or incorrectly assess the impacts of treatment.
To test the hypothesis that localised and non-localised LBP are epidemiologically distinct, 
we analysed data from CUPID (Cultural and Psychosocial Influences on Disability), a large, 
multinational cohort study of musculoskeletal pain and associated disability in selected 
occupational groups [16], looking for differences in severity, associations with risk factors, 
and prognosis of LBP, according to whether or not pain was limited to the low back.
Materials and Methods
The study sample for CUPID comprised men and women from 47 occupational groups 
(mainly nurses, office staff and workers carrying out repetitive manual tasks with their hands 
or arms) in 18 countries. Each of the 12,426 participants (overall response rate 70%) 
completed a baseline questionnaire, either by self-administration or at interview. The 
questionnaire was originally drafted in English and then translated into local languages as 
necessary, accuracy being checked by independent back-translation. Among other things, it 
asked about demographic characteristics, smoking habits, whether an average working day 
entailed lifting weights ≥25 kg, various psychosocial aspects of work, somatising tendency, 
mental health, beliefs about back pain, and experience of musculoskeletal pain during the 
past 12 months.
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Somatising tendency was ascertained through questions taken from the Brief Symptom 
Inventory [17], and classified according to how many of five common somatic symptoms 
(faintness or dizziness, pains in the heart or chest, nausea or upset stomach, trouble getting 
breath and hot or cold spells) had caused at least moderate distress during the past week. 
Mental health was assessed through the relevant section of the Short Form 36 (SF-36) 
questionnaire [18], and scores were graded to three levels (good, intermediate or poor) 
representing approximate thirds of the distribution across the study sample. Participants 
were classed as having adverse beliefs about the work-relatedness of back pain if they 
completely agreed that such pain is commonly caused by work; about its relationship to 
physical activity if they completely agreed that for someone with back pain, physical activity 
should be avoided as it might cause harm, and that rest is needed to get better; and about its 
prognosis if they completely agreed that neglecting such problems can cause serious harm, 
and completely disagreed that such problems usually get better within three months.
The questions about musculoskeletal pain used diagrams to define 10 anatomical regions of 
interest (low back; neck; and right and left shoulder, elbow, wrist/hand and knee). 
Participants were asked whether during the past 12 months, they had experienced pain 
lasting for a day or longer at these sites, and those who reported LBP were also asked 
whether the pain had occurred in the past month, whether it had spread down the leg to 
below the knee (sciatica), how long in total it had been present during the past month and 
past 12 months, whether during the past month it had made it difficult or impossible to cut 
toe nails, get dressed or do normal jobs around the house (disabling pain), whether it had led 
to medical consultation during the past 12 months, the total duration of any resultant 
sickness absence from work during the past 12 months, and whether the most recent episode 
had started suddenly while at work, suddenly while not at work or gradually (an episode of 
pain was defined as occurring after a period of at least one month without the symptom).
After an interval of approximately 14 months, participants from 45 of the occupational 
groups were asked to complete a short follow-up questionnaire, which again asked about 
LBP in the past month.
Further details of the methods of data collection, specification of variables, and 
characteristics of the study sample have been reported elsewhere [16]. Approval for the 
study was provided by the relevant research ethics committees in each participating country 
[16].
Statistical analysis was carried out with Stata software (Stata Corp LP 2012, Stata Statistical 
Software: Release 12.1,College Station TX, USA). From the baseline questions about pain, 
we distinguished participants who reported: LBP in the past month but no pain at any other 
site during the past 12 months (“localised LBP”); LBP in the past month with pain at one or 
more other sites during the past 12 months (“non-localised LBP”); and no LBP at any time 
during the past 12 months. We used simple descriptive statistics to compare the features of 
localised and non-localised LBP, including the prevalence of continuing LBP (i.e. present in 
the past month) at follow-up. Associations with risk factors were explored by Poisson 
regression, and summarised by prevalence rate ratios (PRRs) with 95% confidence intervals 
(CIs) based on robust standard errors. To account for possible clustering by occupational 
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group, we fitted random-intercept models. A scatter plot was used to explore the correlation 
of localised and non-localised LBP across the 47 occupational groups after adjustment for 
other risk factors. To derive adjusted prevalence rates, we took no LBP in the past 12 months 
as a comparator, and first estimated PRRs for the two pain outcomes in each occupational 
group relative to a reference (office workers in the UK), using Poisson regression models 
that included the other risk factors. We then calculated the “adjusted numbers” of 
participants in each occupational group with the two pain outcomes that would give crude 
PRRs equal to those estimated from the regression model. Finally, we used these adjusted 
numbers to calculate adjusted prevalence rates.
Results
From the total of 12,426 participants who completed the baseline questionnaire, we 
excluded 149 because of missing information about LBP in the past month (122), 12 months 
(2) or both (25), and a further 80 who did not provide full responses regarding pain at other 
anatomical sites in the past 12 months. Among the remaining 12,197 subjects (35% men), 
609 (5.0%) reported localised LBP in the past month, and 3,820 (31.3%) non-localised LBP.
Table 1 compares the characteristics of the pain in these two groups of people with low back 
symptoms. Non-localised LBP was more frequently associated with sciatica (48.1% vs. 
30.0% in past month), occurred on more days in the past month and past year, was more 
often disabling for everyday activities (64.1% vs. 47.3%), and had more frequently led to 
medical consultation and sickness absence from work during the past year. However, there 
was no difference between the categories of LBP in the prevalence of sudden as opposed to 
gradual onset.
Table 2 summarises the associations of localised and non-localised LBP with various risk 
factors. The comparator in this analysis was no LBP at any time in the past 12 months (n = 
5,501). Non-localised LBP was significantly more common in women than men, and at 
older ages, whereas the prevalence of localised LBP was significantly higher in men, and 
varied little with age. Somatising tendency was much more strongly related to non-localised 
LBP (PRR 1.7, 95%CI 1.5-1.8 for report of distress from two or more somatic symptoms) 
than localised LBP (PRR 1.1, 95%CI 0.9-1.4). Associations with non-localised pain were 
stronger also for poor mental health and report of time pressure at work. Direct comparison 
of participants with localised and non-localised LBP in a single Poisson regression model 
(effectively taking those with non-localised LBP as cases and those with localised LBP as 
controls) indicated that the differences in associations with sex, age and somatising tendency 
were all highly significant statistically (p < 0.001).
Figure 1 shows the one-month prevalence of localised and non-localised LBP by 
occupational group, after adjustment for all of the risk factors in Table 2. Rates of localised 
LBP ranged from zero among postal workers in New Zealand and 1.0% in office workers in 
Nicaragua to 11.9% in Sri Lankan nurses, and 12.6% in Brazilian sugar cane cutters. For 
non-localised LBP, the absolute variation in prevalence was even greater – from 3.9% in 
Brazilian sugar cane cutters and 6.8% among office workers in Pakistan to 28.1% in 
Brazilian office workers and 28.8% in Brazilian nurses. However there was no clear 
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relationship between the two categories of LBP. Thus, as illustrated in Figure 2, the 
proportion of all back pain cases that were localised varied substantially, but did not 
consistently rise or fall as the overall prevalence of LBP increased (Spearman correlation 
coefficient = –0.37).
Among the 11,764 participants from whom follow-up data were sought, 9,188 (78%) 
provided satisfactory information about LBP at a mean of 14 months (range 3-35 months, 
84% within 11-19 months) after baseline. Table 3 shows the prevalence of continuing LBP 
at follow-up according to the features of pain at baseline. Overall, persistence of pain was 
more frequent when initially it was non-localised (65.6%) than when it was localised 
(54.1%). Moreover, both categories of pain were more likely to be persistent if there was 
associated sciatica at baseline.
Discussion
In this large international study, we found that most LBP (86%) was non-localised. In 
comparison with localised LBP, non-localised LBP tended to be more troublesome, 
disabling and persistent, and showed distinctive associations with risk factors. In addition, 
the two categories of LBP differed markedly in their relative prevalence across the 47 
occupational groups that were studied.
Apart from occupational group, all of the information that was analysed came from 
questionnaires. Pain, somatising tendency, mental health and health beliefs are all best 
assessed through self-report. However, it is possible that reliance on participants’ recall led 
to inaccuracies in other variables such as smoking habits and exposure to heavy lifting at 
work. If so, the impact on risk estimates will have depended on whether errors differed 
systematically according to report of pain. If they were non-differential with respect to pain, 
then any resultant bias will have been towards the null. On the other hand, if they varied by 
pain status (e.g. if participants with LBP tended to report heavy lifting more completely than 
those who were pain-free), then risk estimates could have been spuriously exaggerated. 
However, even if such biases occurred, it seems unlikely that they would have differed 
importantly according to whether or not LBP was localised.
A particular methodological challenge in the CUPID study was the possibility that despite 
our efforts to minimise errors in translation of the questionnaires, terms for pain might be 
understood differently in different cultures. However, misunderstandings are less likely to 
have occurred in determining the anatomical location of symptoms, which was assisted by 
the use of diagrams. Thus, while some of the differences between occupational groups in the 
overall prevalence of LBP may have been a linguistic artefact, variations in the proportion of 
LBP that was localised are likely to be more reliable.
It seems unlikely that the differences which we found between localised and non-localised 
LBP could be explained by selective participation in the study. Eligibility for inclusion 
depended only on participants’ employment in designated jobs and being in the specified 
age range, and response rates were relatively high both at baseline and at follow-up. 
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Moreover, we can think of no reason why responders should differ from non-responders 
differentially in relation to associations with non-localised as compared with localised LBP.
In comparison with localised LBP, non-localised LBP was more persistent and more often a 
cause of disability, sickness absence from work and medical consultation. This accords with 
the observation in a Dutch study that among industrial workers with LBP, those whose pain 
was disabling or had lasted for longer than three months were more likely to have 
musculoskeletal co-morbidity [14], although in that investigation rates of sickness absence 
and medical care-seeking were only marginally higher in subjects whose LBP was 
accompanied by pain in the upper extremity. Also, in a community-based Norwegian 
investigation, functional ability was better among participants with localised LBP than in 
those who reported LBP as part of widespread pain [12]. These differences may occur 
because people who report pain at multiple sites have a generally lower threshold for 
awareness and intolerance of symptoms.
Before performing our analysis, we speculated that sudden onset and associated sciatica 
might be indications that LBP arises from acute injury or other localised spinal pathology, 
and therefore would be more common among people with localised LBP. However, we 
found no evidence for such a relationship. On the contrary, sciatica was more prevalent 
among participants with non-localised LBP than in those whose LBP was localised.
Previous analysis of the CUPID dataset has indicated that multi-site musculoskeletal pain is 
more common in women than men, and at older ages [15]. It is therefore unsurprising that 
non-localised LBP showed similar associations. In marked contrast, however, localised LBP 
was more frequent among men than women, and tended to have higher prevalence at 
younger ages. This is consistent with findings from a community-based survey in Norway 
[12].
After adjustment for sex and age, both localised and non-localised LBP were associated with 
smoking, heavy lifting, somatising tendency, poor mental health, adverse beliefs about 
occupational causation and the prognosis of LBP, and less clearly with some psychosocial 
aspects of work (Table 2). Because the analysis was cross-sectional, these associations 
cannot necessarily be interpreted as causal, although they are consistent with findings from 
other studies [3,5–8,19,20]. Of greater interest are the differences in the strength of the 
relationships according to whether LBP was localised or associated with pain at other 
anatomical sites. As well as somatising tendency, poor mental health and several 
psychosocial aspects of work showed significantly stronger associations with non-localised 
LBP. This could occur if the psychological risk factors were associated with proneness to 
pain more generally, and not specifically in the low back.
We are aware of only one other study that has compared the epidemiology of localised and 
non-localised LBP [12], and that did not investigate multiple risk factors as we have done. 
However, a prospective cohort study in Germany of patients who consulted general 
practitioners with chronic LBP, but in whom pain was not at the time widespread, found that 
transition to chronic widespread pain at follow-up was associated with female sex and a high 
rate of psychosomatic symptoms [21,22]. Non-localised LBP, as we defined it, would not 
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necessarily be classed as chronic widespread pain – the pain may have occurred at only one 
other anatomical site in addition to the low back, and may have been only short-lived. 
Moreover, we do not know whether the onset of pain in the low back preceded or followed 
that at other anatomical sites. Nevertheless, our observation that non-localised LBP was 
differentially associated with female sex and somatising tendency is consistent with the 
results of the German study.
When the risk factors in Table 2 were taken into account, there were also marked differences 
in the relative prevalence of localised and non-localised LBP by occupational group. Thus 
the proportion of LBP that was localised varied from zero in New Zealand postal workers to 
76.4% among sugar cane cutters in Brazil, with a tendency to be lower when the overall 
prevalence of LBP was higher (Figure 2). This again is an indication that localised LBP is 
epidemiologically distinct.
Our study sample was limited to men and women in employment, and we cannot be certain 
that the differences which were found between localised and non-localised LBP in severity, 
associations with risk factors, and prognosis, would be the same in all populations. However, 
their observation in a large sample of workers from 18 countries across five continents is 
sufficient to demonstrate that potentially important epidemiological differences do occur. 
This suggests that where possible, epidemiological studies on the causes and prognosis of 
LBP should distinguish pain that is limited to the low back from that which occurs in 
association with pain at other anatomical locations.
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Mini abstract
In a large international cohort study, pain that was confined to the low back was less 
prevalent than that which affected the low back as part of a wider anatomical distribution, 
and differed in its severity, associations with risk factors, and prognosis.
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Key Points
• In a large international survey, most low back pain was accompanied by 
current or recent pain at other anatomical sites.
• In comparison with pain that was localised entirely to the low back, that 
which was associated with pain elsewhere was more troublesome and 
persistent, and differed importantly in its associations with risk factors.
• After adjustment for other risk factors, localised and non-localised LBP also 
differed in their relative prevalence by occupational group.
• Future epidemiological studies should distinguish where possible between 
pain that is limited to the low back, and that which occurs in association with 
pain at other anatomical sites.
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Figure 1. One-month prevalence of localised and non-localised low back pain by occupational 
group
Prevalence rates are adjusted for all of the risk factors in Table 2
Key to countries: AU Australia; BR Brazil; CO Colombia; CR Costa Rica; EC Ecuador; EE 
Estonia; GR Greece; IR Iran; IT Italy; JP Japan; LB Lebanon; LK Sri Lanka; NI Nicaragua; 
NZ New Zealand; PK Pakistan; SA South Africa; SP Spain; UK United Kingdom
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Figure 2. Proportion of low back pain that was localised according to overall prevalence of low 
back pain in each occupational group
Prevalence rates are adjusted for all of the risk factors in Table 2
Key to countries: AU Australia; BR Brazil; CO Colombia; CR Costa Rica; EC Ecuador; EE 
Estonia; GR Greece; IR Iran; IT Italy; JP Japan; LB Lebanon; LK Sri Lanka; NI Nicaragua; 
NZ New Zealand; PK Pakistan; SA South Africa; SP Spain; UK United Kingdom
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Table 1
Characteristics of localised and non-localised low back pain
Characteristic Localised low back pain (n = 609) Non-localised low back pain (n = 3,820)
N % (95%CI) N % (95%CI)
Sciatica in past month 183 30.0 (26.4,33.9) 1,836 48.1 (46.5,49.7)
Sciatica in past 12 months 233 38.3 (34.4,42.3) 2,238 58.6 (57.0,60.2)
Total duration in past month
    1-6 days 369 60.6 (56.6,64.5) 2,067 54.1 (52.5,55.7)
    1-2 weeks 123 20.2 (17.1,23.6) 783 20.5 (19.2,21.8)
    >2 weeks 112 18.4 (15.4,21.7) 947 24.8 (23.4,26.2)
    Not known 5 0.8 23 0.6
Total duration in past 12 months
    1-6 days 180 29.6 (26.0,33.4) 740 19.4 (18.1,20.7)
    1-4 weeks 263 43.2 (39.2,47.2) 1,661 43.5 (41.9,45.1)
    1-12 months 162 26.6 (23.1,30.3) 1,403 36.7 (35.2,38.3)
    Not known 4 0.7 16 0.4
Disabling in past month 288 47.3 (43.3,51.3) 2,447 64.1 (62.5,65.6)
Led to medical consultation in past 12 months 255 41.9 (37.9,45.9) 1,974 51.7 (50.1,53.3)
Attributed sickness absence in past 12 months (days)
    0 475 78.0 (74.4,81.2) 2,707 70.9 (69.4,72.3)
    1-5 83 13.6 (11.0,16.6) 674 17.6 (16.4,18.9)
    6-30 29 4.8 (3.2,6.8) 238 6.2 (5.5,7.0)
    >30 10 1.6 (0.8,3.0) 85 2.2 (1.8,2.7)
    Not known 12 2.0 116 3.0
Onset of most recent episode
    Sudden while at work 167 27.4 (23.9,31.2) 1,176 30.8 (29.3,32.3)
    Sudden not while at work 110 18.1 (15.1,21.4) 530 13.9 (12.8,15.0)
    Gradual 318 52.2 (48.2,56.2) 2,015 52.7 (51.2,54.3)
    Not known 14 2.3 99 2.6
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Table 2
Associations of localised and non-localised low back pain with personal and occupational 
risk factors
Risk factor No low back pain in past 12 months Localised low back pain Non-localised low back pain
N N PRRa (95%CI) N PRRa (95%CI)
Sex
      Male 2,265 292 1 943 1
      Female 3,236 317 0.8 (0.6,0.9) 2,877 ***1.2 (1.1,1.3)
Age (years)
      20-29 1,502 175 1 783 1
      30-39 1,737 208 1.0 (0.8,1.2) 1,189 **1.1 (1.1,1.2)
      40-49 1,446 147 0.9 (0.7,1.1) 1,203 ***1.2 (1.1,1.4)
      50-59 816 79 0.9 (0.7,1.1) 645 ***1.2 (1.1,1.4)
Smoking
      Never smoked 3,631 339 1 2,349 1
      Ex-smoker 727 91 1.3 (1.0,1.7) 579 1.1 (1.1,1.2)
      Current smoker 1,124 176 1.3 (1.0,1.7) 885 1.1 (1.1,1.3)
      Not known 19 3 7
Activity in average working day
      Lifting weights ≥25 kg 1,684 266 1.4 (1.2,1.7) 1,599 1.2 (1.1,1.3)
Psychosocial aspects of work
      Work for >50 hours per week 1,394 176 1.0 (0.8,1.3) 601 †1.0 (0.9,1.1)
      Time pressure at work 3,948 456 1.0 (0.8,1.2) 3,046 *1.2 (1.1,1.3)
      Incentives at work 1,605 168 0.9 (0.7,1.1) 1,054 1.0 (0.9,1.1)
      Lack of support at work 1,104 126 1.0 (0.8,1.3) 1,190 **1.1 (1.0,1.2)
      Job dissatisfaction 1,087 128 0.9 (0.8,1.1) 817 1.0 (0.9,1.2)
      Lack of job control 1,136 134 1.1 (0.9,1.3) 864 1.0 (1.0,1.1)
      Job insecurity 1,652 220 1.1 (1.0,1.3) 1,277 1.1 (1.0,1.2)
Number of distressing somatic symptoms in past week
      0 3,871 406 1 1,631 1
      1 983 127 1.2 (1.0,1.5) 943 ***1.4 (1.3,1.5)
      2+ 596 70 1.1 (0.9,1.4) 1,200 ***1.7 (1.5,1.8)
      Missing 51 6 46
Mental health
      Good 2,417 225 1 1,137 1
      Intermediate 1,628 181 1.1 (0.9,1.3) 1,157 1.2 (1.1,1.3)
      Poor 1,418 198 1.2 (1.0,1.5) 1,504 **1.4 (1.3,1.5)
      Missing 38 5 22
Adverse beliefs about back pain
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Risk factor No low back pain in past 12 months Localised low back pain Non-localised low back pain
N N PRRa (95%CI) N PRRa (95%CI)
      Work-relatedness 1,472 215 1.3 (1.1,1.5) 1,617 *1.3 (1.2,1.3)
      Physical activity 999 119 0.9 (0.7,1.1) 669 0.9 (0.9,1.0)
      Prognosis 598 86 1.2 (1.0,1.4) 709 **1.2 (1.1,1.3)
a
Prevalence rate ratios relative to no low back pain in past 12 months derived from a single Poisson regression model for each pain outcome, with 
random intercept modelling to allow for clustering by occupational group
*
Risk significantly higher for non-localised when compared directly with localised low back pain (p<0.05)
**
Risk significantly higher for non-localised when compared directly with localised low back pain (p<0.01)
***
Risk significantly higher for non-localised when compared directly with localised low back pain (p<0.001)
†
Risk significantly lower for non-localised when compared directly with localised low back pain (p<0.01)
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Table 3
One-month prevalence of low back pain at follow-up according to localisation of low back 
pain at baseline
Analysis was restricted to the 9,188 cases with satisfactory information about low back pain at follow-up
Category of low back pain at baseline Number of cases at baseline Low back pain in past month at follow-up
Number of cases Prevalence % (95%CI)
Localised with no sciatica in past 12 months 282 144 51.1 (45.1,57.0)
Localised with sciatica in past 12 months 158 94 59.5 (51.4,67.1)
All localised low back pain 440 238 54.1 (49.3,58.8)
Non-localised with no sciatica in past 12 months 1,199 718 59.9 (57.0,62.6)
Non-localised with sciatica in past 12 months 1,695 1,181 69.7 (67.4,71.8)
All non-localised low back pain 2,894 1,899 65.6 (63.8,67.4)
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